According to Wei et al. (315), the hybrid cells created when lung cancer cells and MSCs fuse express stem cell markers, like OCT4, SOX2, NANOG, and KLF4, and demonstrate enhanced metastatic potential and epithelial-to-mesenchymal transition (EMT). The gene discussed is SOX2; the disease is lung carcinoma.